Table 2 Association between exposure variables and suicide risk
From: Association between benzodiazepines and suicide risk: a matched case-control study
Variables | Cases n (%) | Controls n (%) | Unadjusted | Adjusteda,b | ||
|---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |||
Psychopharmaceutical prescription | ||||||
Benzodiazepine | 65 (42.2) | 43 (27.9) | 1.89 (1.17–3.03) | 0.009 | 1.83 (1.06–3.14) | 0.029 |
Antidepressant | 105 (68.2) | 107 (69.5) | 0.94 (0.58–1.53) | 0.806 | 0.88 (0.50–1.56) | 0.654 |
Anticonvulsant | 36 (23.4) | 37 (24.0) | 0.97 (0.57–1.63) | 0.893 | 0.89 (0.50–1.60) | 0.697 |
Lithium | 6 (3.9) | 8 (5.2) | 0.74 (0.25–2.19) | 0.586 | 0.77 (0.20–2.90) | 0.696 |
Psychostimulant | 6 (3.9) | 6 (3.9) | 1.00 (0.32–3.17) | 1.000 | 0.96 (0.24–3.86) | 0.950 |
Antipsychotic | 37 (24.0) | 39 (25.3) | 0.93 (0.56–1.57) | 0.792 | 0.83 (044–1.58) | 0.572 |
Sedative | 98 (63.6) | 89 (57.8) | 1.28 (0.81–2.02) | 0.294 | 1.29 (077–2.18) | 0.332 |
Previous suicide attempt | 30 (19.5) | 14 (9.1) | 2.42 (1.28–4.77) | 0.011 | 2.12 (1.01–4.44) | 0.047 |
Previous inpatient psychiatric care | 80 (51.9) | 75 (48.7) | 0.88 (0.56–1.37) | 0.569 | 1.07 (0.64–1.79) | 0.798 |
Previous inpatient somatic care | 50 (32.5) | 30 (19.5) | 1.99 (1.18–3.35) | 0.010 | 1.69 (0.95–3.01) | 0.074 |